WEST PHARMACEUTICAL SERVICES INC

WST NYSE CIK: 0000105770

Company Information

Industry Surgical & Medical Instruments & Apparatus
SIC Code 3841
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation PA
Business Address 530 HERMAN O. WEST DRIVE, EXTON, PA, 19341
Mailing Address 530 HERMAN O. WEST DRIVE, EXTON, PA, 19341
Phone 6105942900
Fiscal Year End 1231
EIN 231210010

Financial Overview

FY2025

$1.09B
Total Liabilities
$3.18B
Stockholders' Equity

Recent SEC Filings

Form Type Date Filed Document
SCHEDULE 13G/A Passive ownership amendment March 27, 2026 View on SEC
DEF 14A Definitive proxy statement March 12, 2026 View on SEC
8-K Current report of material events March 9, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC
4 Insider stock transaction report March 3, 2026 View on SEC

Annual Reports

10-K February 17, 2026
  • Robust financial performance with total revenue climbing 7.8% to $3.45 billion and net income reaching $620 million.
  • Strategic portfolio refinement by classifying the SmartDose 3.5mL On-Body Delivery System as 'held for sale' to focus on higher-growth opportunities.
View Analysis

Material Events

8-K Leadership Change March 9, 2026
High Impact
  • CEO Eric Green announces planned retirement, ensuring an orderly and seamless transition.
  • West Pharma reaffirms strong full-year 2026 financial guidance despite the upcoming leadership change.
View Analysis

Related Companies

Companies in the same industry (SIC: 3841)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.